FDA Inspection 1207607 — Thymoorgan Pharmazie Gmbh

Thymoorgan Pharmazie Gmbh — FEI 3002320821

The FDA completed an inspection of Thymoorgan Pharmazie Gmbh on October 6, 2022 in Goslar. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 6, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Goslar (Germany)

Additional Details

Mutual Recognition Agreement (MRA)